Jean-Philippe Lacour
15PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Feb 06, 2026
Real-World Use of Dupilumab in Atopic Dermatitis: Observational Study Results Linked to SNDS.Alain Dupuy, Anne-Claire Fougerousse, Pierre-André Bécherel
|Jun 14, 2022
Perialar intertrigo in children and adolescents: A multicenter prospective study of 41 cases.Adrien Sanchez, Emmanuel Mahe, Juliette Miquel
|Apr 23, 2022
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.A P Fernandez, E Dauden, S Gerdes
|Oct 01, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).A Wollenberg, A Blauvelt, E Guttman-Yassky
|Aug 21, 2020
Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate-to-severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI-PSO study.M-A Richard, J-P Lacour, M-P Konstantinou
|Oct 19, 2019
Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma.C Bence, V Hofman, E Chamorey
Pageof 3
